In a potential marriage that analysts said faces long odds, AstraZeneca and Bristol Myers Squibb have held talks on a merger that would create the world’s largest drugmaker by revenue and rank among the biggest deals in pharmaceutical history, the Financial Times reported. The merger would also mark the most significant reshaping of pharma’s top…